Insulin Aspart Protamine and Insulin Aspart Mix 70/30 Injectable Suspension — FDA Drug Shortage

No longer listed by FDA — Novo Nordisk, Inc.

The FDA lists a drug shortage record for Insulin Aspart Protamine and Insulin Aspart Mix 70/30 Injectable Suspension (injectable suspension) from Novo Nordisk, Inc. with status No longer listed by FDA. The shortage was first posted on Jul 21, 2025.

Shortage details

Status
No longer listed by FDA
Company
Novo Nordisk, Inc.
Package NDC
73070-200-11
Dosage Form
Injectable Suspension
Presentation
Insulin Aspart Protamine and Insulin Aspart Mix 70/30, Injectable Suspension, 10 mL Insulin aspart protamine and insulin aspart Mix 70/30 vial (NDC 73070-200-11)
Initial Posting
Jul 21, 2025

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.